Annexon Inc (ANNX)
4.88
+0.22
(+4.72%)
USD |
NASDAQ |
May 03, 16:00
5.03
+0.15
(+3.07%)
After-Hours: 20:00
Annexon Cash from Operations (Quarterly): -23.48M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.48M |
| September 30, 2023 | -28.29M |
| June 30, 2023 | -36.38M |
| March 31, 2023 | -32.99M |
| December 31, 2022 | -27.14M |
| September 30, 2022 | -30.72M |
| June 30, 2022 | -28.16M |
| March 31, 2022 | -30.29M |
| December 31, 2021 | -28.32M |
| September 30, 2021 | -29.72M |
| Date | Value |
|---|---|
| June 30, 2021 | -24.63M |
| March 31, 2021 | -23.44M |
| December 31, 2020 | -19.26M |
| September 30, 2020 | -13.58M |
| June 30, 2020 | -10.25M |
| March 31, 2020 | -10.00M |
| December 31, 2019 | -8.789M |
| September 30, 2019 | -6.87M |
| June 30, 2019 | -6.696M |
| March 31, 2019 | -6.003M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.38M
Minimum
Jun 2023
-6.696M
Maximum
Jun 2019
-22.05M
Average
-24.63M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Trxade Health Inc | -0.8675M |
| P3 Health Partners Inc | -15.88M |
| Arrowhead Pharmaceuticals Inc | -117.84M |
| Insmed Inc | -130.82M |
| Heron Therapeutics Inc | 2.455M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.183M |
| Cash from Financing (Quarterly) | 117.60M |
| Free Cash Flow | -121.34M |
| Free Cash Flow Per Share (Quarterly) | -0.3001 |
| Free Cash Flow Yield | -32.86% |